Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CARTER CLINIC PA

NPI: 1942874938 · LAURINBURG, NC 28352 · Community/Behavioral Health Agency · NPI assigned 05/14/2021

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official HARRISON, MYLEME controls 11+ related entities in our dataset. Read more

$111K
Total Medicaid Paid
1,801
Total Claims
829
Beneficiaries
6
Codes Billed
2021-11
First Month
2023-12
Last Month

Provider Details

Authorized OfficialHARRISON, MYLEME (CEO/OWNER)
NPI Enumeration Date05/14/2021

Related Entities

Other providers sharing the same authorized official: HARRISON, MYLEME

ProviderCityStateTotal Paid
CARTER CLINIC, P A RALEIGH NC $19.47M
CARTER CLINIC PA WILMINGTON NC $3.16M
CARTER CLINIC, P A LUMBERTON NC $3.12M
CARTER CLINIC, PA FAYETTEVILLE NC $2.57M
CARTER CLINIC, PA RED SPRINGS NC $1.78M
CARTER CLINIC PA SMITHFIELD NC $1.51M
CARTER CLINIC, P.A. WILSON NC $1.20M
CARTER CLINIC, P A ELIZABETHTOWN NC $639K
CARTER CLINIC, P.A. SHELBY NC $149K
CARTER CLINIC, PA WHITEVILLE NC $63K
CARTER CLINIC, PA DUNN NC $48K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 196 $4K
2022 723 $52K
2023 882 $56K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
90837 Psychotherapy, 53 minutes with patient 1,047 425 $79K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 333 177 $18K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 206 118 $13K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 69 57 $2K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 72 26 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 74 26 $0.00